Thursday, January 18, 2018

(LML) InfoNTD mail with the latest publications on cross-cutting issues and NTDs - January 2018

 



Leprosy Mailing List – January 18,  2017

Ref.: (LML) InfoNTD mail with the latest publications on cross-cutting issues and NTDs -   January 2018

From:  Ilse Egers, Amsterdam, the Netherlands

 

 


 

Dear Pieter,

 

This is the first InfoNTD newsletter of 2018. Wishing you all a healthy new year!

The newsletter provides you with a selection of news items and recent publications on cross-cutting issues in NTDs. Our starting point is to add articles covering a wide variety of issues. Unfortunately, this is not always possible due to a limited diversity in and shortage of articles on cross-cutting issues and NTDs.

Feel free to contact us with any questions or to receive the PDF if a link to the full text is not included. Our document delivery service is free!

Ilse Egers
InfoNTD Information officer
 

 

https://cdn-images.mailchimp.com/icons/social-block-v2/color-forwardtofriend-48.png

Email

 

https://cdn-images.mailchimp.com/icons/social-block-v2/color-link-48.png

InfoNTD Portal

 

https://cdn-images.mailchimp.com/icons/social-block-v2/color-twitter-48.png

Twitter

 

 

 

 

 


 

News
 


New Partnership to Fight Schistosomiasis in Ethiopia
ADDIS ABABA, Ethiopia,-/African Media Agency (AMA)/- Merck, a leading science and technology company, today officially signed a three-year partnership with the NALA Foundation to create greater awareness of schistosomiasis in Ethiopia. The NALA Foundation, a non-governmental organization fighting against the root causes of Neglected Tropical Diseases, will support the Ethiopian Federal Ministry of Health by applying a community participatory approach. With this newly launched project, Merck is expanding its schistosomiasis-related health education and awareness activities in Africa.
Read more:

 


 


 


 


 

New publications

 


 

Patient-centered communication of community treatment assistants in Tanzania predicts coverage of future mass drug administration for trachoma.
Jenson A, Roter DL, Mkocha H, et al. Patient Educ Couns. 2018.
Abstract Prevention of Trachoma, the leading cause of infectious blindness, requires community treatment assistants (CTAs) to perform mass drug administration (MDA) of azithromycin. Previous research has shown that female CTAs have higher MDA coverage, but no studies have focused on the content of conversation. We hypothesize that female CTAs had more patient-centered communication and higher MDA coverage.
Read more


Financial burden of health care for Buruli ulcer patients in Nigeria: the patients' perspective.
Chukwu JN, Meka AO, Nwafor CC, et al. Int Health. 2017; 9(1):36-43.
Abstract The economic burden of Buruli ulcer for patients has not been well-documented. This study assessed the costs of Buruli ulcer care to patients from the onset of illness to diagnosis and to the end of treatment. This was a cross-sectional cost of illness study conducted among patients with Buruli ulcer in four States in Nigeria between July and September 2015.
Read more


Mapping the geographical distribution of podoconiosis in Cameroon using parasitological, serological, and clinical evidence to exclude other causes of lymphedema.
Deribe K, Beng AA, Cano J, et al. PLoS Negl Trop Dis. 2018; 12(1):e0006126.
Abstract Podoconiosis is a non-filarial elephantiasis, which causes massive swelling of the lower legs. It was identified as a neglected tropical disease by WHO in 2011. Understanding of the geographical distribution of the disease is incomplete. As part of a global mapping of podoconiosis, this study was conducted in Cameroon to map the distribution of the disease. This mapping work will help to generate data on the geographical distribution of podoconiosis in Cameroon and contribute to the global atlas of podoconiosis.
Download PDF


Adherence and quality of life.
Ridner S, Deng J, Rhoten BA. Lymphedema. 2018:493-501.
Abstract Individuals with lymphedema navigate a particularly complex treatment and self-management regimen, making adherence difficult. It is essential that these individuals conduct lifelong self-care activities to control the progression of swelling, manage lymphedema-associated symptom burden, and minimize long-term negative outcomes (e.g., elephantiasis). We postulate that adherence to lymphedema management behaviors decreases symptom burden (i.e., progressive increases in swelling, infection, etc.) and thus facilitates an increase in health-related quality of life.
Read more


We Decide: An initiative by the UNFPA to fight for the rights of disabled individuals.
Shrivastava SR, Shrivastava PS, Ramasamy J. Annals of tropical medicine and public health. 2017; 10(6):1843-1844.
Download PDF


Expanding the coverage of preventive chemotherapy for the prevention and control of neglected tropical diseases.
Shrivastava SR, Shrivastava PS, Ramasamy J. Annals of tropical medicine and public health. 2017; 10(6):1415-1416.
Download PDF


Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria.
Brant TA, Okorie PN, Ogunmola O, et al. Parasite Epidemiol Control. 2018; 3(1):21–35.
Abstract Nigeria has the heaviest burden of lymphatic filariasis (LF) in sub-Saharan Africa, which is caused by the parasite Wuchereria bancrofti and transmitted by Anopheles mosquitoes. To better understand factors influencing LF elimination in loiasis areas, this study conducted a cross-sectional survey on the prevalence and co-distribution of the two infections, and the potential demographic, landscape, human movement, and intervention-related risk factors at a micro-level in the South West zone of Nigeria.
Download PDF


A study of risk factors associated with poor water and sanitation in Srinagar city, Jammu and Kashmir.
Ahmad Baba S. IJEDR. 2017; 5(4):1133-1140.
Abstract This paper seeks to investigate the risk factors associated with inadequate water and sanitation conditions in the different income households of Srinagar city. The study is based on primary sources of data collected with the help of well-structured questionnaire/schedule from 1500 households during 2013. This study identifies the 8 main water supply and sanitation related risk factors and occurrence of 6 associated diseases.
Download PDF


Elimination of trachoma as a public health problem in Ghana: Providing evidence through a pre-validation survey.
Debrah O, Mensah EO, Senyonjo L, et al. PLoS Negl Trop Dis. 2017; 11(12):e0006099.
Abstract In order to achieve elimination of trachoma, a country needs to demonstrate that the elimination prevalence thresholds have been achieved and then sustained for at least a two-year period. Ghana achieved the thresholds in 2008, and since 2011 has been implementing its trachoma surveillance strategy, which includes community and school screening for signs of follicular trachoma and trichiasis, in trachoma-endemic districts. In 2015-2016, the country conducted a district level population-based survey to validate elimination of trachoma as a public health problem.
Download PDF


The monetary value of human lives lost due to neglected tropical diseases in Africa.
Kirigia JM, Mburugu GN. Infect Dis Poverty. 2017; 6(1):165.
Abstract Neglected tropical diseases (NTDs) are an important cause of death and disability in Africa. This study estimates the monetary value of human lives lost due to NTDs in the continent in 2015.
Download PDF


Ten failings in global neglected tropical diseases control.
Hotez PJ. PLoS Negl Trop Dis. 2017; 11(12):e0005896.
Download PDF


Visual impairment and psychosocial development.
Dawn R. Educational Achievement and Psychosocial Transition in Visually Impaired Adolescents. 2017:15-48.
Abstract This chapter explores various aspects of Self-esteem and adjustment in relation to disability. It critically analyses the various theories and their relevance in affecting the psychological well-being of people with disabilities, particularly blind individuals. The chapter also highlights certain important shortcomings existing in the area of research concerning visual impairment, thus urging the need to undertake more in-depth and extensive research.
Read more


Sustaining visceral leishmaniasis elimination in Bangladesh - Could a policy brief help?
Fitzpatrick A, Al-Kobaisi NSMS, Beitman Maya J, et al. PLoS Negl Trop Dis. 2017; 11(12):e0006081.
Abstract Bangladesh has made significant progress towards elimination of visceral leishmaniasis, and is on track to achieve its target of less than one case per 10,000 inhabitants in each subdistrict in 2017. As the incidence of disease falls, it is likely that the political capital and financial resources dedicated towards the elimination of visceral leishmaniasis may decrease, raising the prospect of disease resurgence. The background to the current elimination efforts is highlighted, with emphasis on remaining uncertainties including the impact of disease reservoirs and sustainable surveillance strategies.
Download PDF


Ethical issues associated with vector-borne diseases.
World Health Organization. 2017:37.
Abstract Vector-borne diseases (VBDs) are associated with heavy burdens, particularly in poor and vulnerable communities. Their transmission by vectors provides opportunities for specific public health interventions and gives rise to unique ethical issues. Despite their growing importance, ethical issues associated with VBDs have not previously been explored comprehensively.
Download PDF


Buruli ulcer, a prototype for ecosystem-related infection, caused by Mycobacterium ulcerans.
Zingue D, Bouam A, Tian RBD, et al. Clin. Microbiol. Rev. 2017; 31(1):e00045-17.
Abstract Buruli ulcer is a noncontagious disabling cutaneous and subcutaneous mycobacteriosis reported by 33 countries in Africa, Asia, Oceania, and South America. The causative agent, Mycobacterium ulcerans, derives from Mycobacterium marinum by genomic reduction and acquisition of a plasmid-borne, nonribosomal cytotoxin mycolactone, the major virulence factor. M. ulcerans-specific sequences have been readily detected in aquatic environments in food chains involving small mammals.
Read more


Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.
Ponte-Sucre A, Gamarro F, Dujardin J-C, et al. PLoS Negl Trop Dis. 2017; 11(12):e0006052.
Abstract In this review, we discuss the meaning of "resistance" related to leishmaniasis and discuss its molecular epidemiology, particularly for Leishmania donovani that causes visceral leishmaniasis. We also discuss how resistance can affect drug combination therapies. Molecular mechanisms known to contribute to resistance to antimonials, amphotericin B, and miltefosine are also outlined.
Download PDF


The impact of global environmental changes on infectious disease emergence with a focus on risks for Brazil.
Nava A, Shimabukuro JS, Chmura AA, et al. ILAR J. 2017.
Abstract Environmental changes have a huge impact on the emergence and reemergence of certain infectious diseases, mostly in countries with high biodiversity and serious unresolved environmental, social, and economic issues. This article summarizes the most important findings with special attention to Brazil and diseases of present public health importance in the country such as Chikungunya, dengue fever, yellow fever, Zika, hantavirus pulmonary syndrome, leptospirosis, leishmaniasis, and Chagas disease.
Read more


Tracking trachoma: How The Gambia is eliminating an ancient disease.
Lewis J. Environ Health Perspect. 2017; 125(12):1-6.
Download PDF


Eucalyptus globulus oil versus bleach use as antiseptic agents in podoconiosis treatment: An interventional study in Wolaita Zone, Southern Ethiopia.
Alemayehu B, Gelibo T, Kanche ZZ. Am J Biomed Life Sci. 2017; 5(6):113-118.
Abstract Eucalyptus globulus essential oil is widely used for medicinal purpose because of its pharmacological constituents. The present study aimed to use water emulsified E. globulus oil as an antiseptic agent in the treatment protocol of podoconiosis (non-filarial elephantiasis) and compare disease improvement upon E. globulus oil versus bleach (usual antiseptic chemical) use in the treatment protocol.
Download PDF


Still neglected? Unprecedented progress and future challenges discussed at the neglected tropical disease summit.
Hopkins A. Trans. R. Soc. Trop. Med. Hyg. 2017:1-3.
Download PDF


Addressing vulnerability, building resilience: community-based adaptation to vector-borne diseases in the context of global change.
Bardosh KL, Ryan S, Ebi K, et al. Infect Dis Poverty. 2017; 6(1):166.
Abstract In this paper, we provide an alternative biosocial perspective grounded in social science insights, drawing upon concepts of vulnerability, resilience, participation and community-based adaptation. Our analysis was informed by a realist review (provided in the Additional file 2) focused on seven major climate-sensitive vector-borne diseases: malaria, schistosomiasis, dengue, leishmaniasis, sleeping sickness, chagas disease, and rift valley fever.
Download PDF


Including refugees in disease elimination: challenges observed from a sleeping sickness programme in Uganda.
Palmer JJ, Robert O, Kansiime F. Confl Health. 2017; 11:22.
Abstract We studied Uganda's response to the recent refugee influx from South Sudan to identify key governance and operational lessons for national sleeping sickness programmes working with displaced populations today. A refugee policy which favours integration of primary healthcare services for refugee and host populations and the availability of rapid diagnostic tests (RDTs) to detect sleeping sickness at this health system level makes Uganda well-placed to include refugees in sleeping sickness surveillance.
Download PDF


Schistosomiasis mansoni diagnosis: Current status and perspectives.
Montenegro SML, Azevedo EAN, Oliveira SAV, et al. Tropical Diseases: An Overview of Major Diseases Occurring in the Americas. 2017.
Abstract Schistosomiasis is considered a neglected tropical disease and remains a major public health problem throughout the tropics and subtropics with significant socioeconomic impact. More than 200 million people are infected worldwide. In this chapter, imaging methods are used not for the diagnosis of schistosomiasis as a disease, but for the diagnosis of morbidity, identifying the changes caused by Schistosoma mansoni infection in the human organism.
Download PDF


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

Wednesday, January 17, 2018

(LML) Good practice in dealing with leprosy patients

Leprosy Mailing List – January 17,  2017

Ref.:    (LML) Good practice in dealing with leprosy patients

From:  Ajit P, Mumbai, India

__________________________________________________________

Respected Sir,


I would like to share a few things I was fortunate to learn while dealing with leprosy and dermatology patients.

 
In my checklist while examining patients and taking history.
I have added three more things:
- I routinely discuss about internet. Guys who have smartphones often search indiscriminately on net, see some pictures and get frightened or are misinformed or try some self remedies. In Bandra, West Mumbai, where I practice I get Hansen patients from poor socioeconomic class but some of them have internet enabled smartphones. I also tell which websites are reliable.
- I routinely discuss myths and debunk them.
- I routinely discuss alternative medicine. As guys are attracted to natural therapies and may leave proven effective therapy and take alternative medicine. I warn them of the dangers.
"Complications are best managed by anticipation"-
Bailey&love"s  Short Practice of Surgery.


One more practice that I employ for trophic ulcer prevention is to tell the patient that loss of sensation often persists
and so you won't get pain and hence won't be aware of minor injuries. To prevent I tell them to see their hands feet and other insensitive areas under light every day before sleeping or after bath and check if there are any minor cuts. Those who have cell phones, I make them put an alarm or reminder for this in front of me.


"I was pricked poked and probed but not touched" Mother Teresa. It is not just sufficient to tell patients that leprosy is not spread by touch. One must actually touch the patient with ungloved hand to emphasize this.


Dr Ajit

Dermatologist, Bandra, West Mumbai, India

___________________________________________________________________

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

 

 

Tuesday, January 16, 2018

(LML) Supreme Court of India and discrimatory laws

Leprosy Mailing List – January 16,  2017

Ref.:   (LML)  Supreme Court of India and discrimatory laws

From:  Joel Almeida, Mumbai and London


Dear Pieter,

 

A non-governmental organization in India petitioned the Supreme Court to declare as unconstitutional those laws which discriminate against people suffering from leprosy.

 

The central government responded by stating its intention to take remedial action against discriminatory laws.

 

The Supreme Court also directed the state governments to take similar action so that there will be no such discrimination.

 

https://drive.google.com/file/d/1bKPhpx8mT84DarCDXgHWs60AVj-Zw0co/view

 

This is another milestone for not just people affected by leprosy, but also for astute use of the courts in India.

 

The Supreme Court had, in response to previous public interest litigation, directed the government to intensify its efforts against leprosy, to appoint sufficient leprosy workers, and to publish the concealed findings of sample surveys that were apparently inconsistent with claims of a decline in leprosy in India.

 

Congratulations to all those who worked to make such changes happen.

 

Joel Almeida

 

 

Note editor: It is likely that there are more countries with such laws. How about your country and if so what could be done about it?


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

 

(LML) Supreme Court of India and discrimatory laws

Leprosy Mailing List – January 16,  2017

Ref.:   (LML)  Supreme Court of India and discrimatory laws

From:  Joel Almeida, Bombai and London


Dear Pieter,

 

A non-governmental organization in India petitioned the Supreme Court to declare as unconstitutional those laws which discriminate against people suffering from leprosy.

 

The central government responded by stating its intention to take remedial action against discriminatory laws.

 

The Supreme Court also directed the state governments to take similar action so that there will be no such discrimination.

 

https://drive.google.com/file/d/1bKPhpx8mT84DarCDXgHWs60AVj-Zw0co/view

 

This is another milestone for not just people affected by leprosy, but also for astute use of the courts in India.

 

The Supreme Court had, in response to previous public interest litigation, directed the government to intensify its efforts against leprosy, to appoint sufficient leprosy workers, and to publish the concealed findings of sample surveys that were apparently inconsistent with claims of a decline in leprosy in India.

 

Congratulations to all those who worked to make such changes happen.

 

Joel Almeida

 

 

Note editor: It is likely that there are more countries with such laws. How about your country and if so what could be done about it?


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

Sunday, January 14, 2018

(LML) Infolep update on new leprosy publications – January 2018

Leprosy Mailing List – January 14,  2017

Ref.:  (LML) Infolep update on new leprosy publications – January 2018 

From:  Jiske Erlings, Amsterdam, the Netherlands


Dear Pieter and LML readers,

 

Happy New Year and welcome to the first Infolep mailing of 2018.

Did you know that the Infolep portal gives you access to over
27,380 publications on leprosy (with 1,180 items added in 2017).  The purpose of this monthly newsletter is to inform you about recent publications on leprosy and related subjects.  Feel free to contact me to receive the full text versions if a link to the full text is not provided. Assistance with your literature research is also possible. Do you have any leprosy research or training material you would like to share? Please send me an e-mail (infolep@leprastichting.nl).

We would like to thank our partners American Leprosy Missions, DAHW, Damien Foundation, Fairmed, Fontilles, Fondation Raoul Follereau, Lepra, Leprosy Relief Canada and Netherlands Leprosy Relief for their continued support. With their help we can continue to strive for the best possible leprosy information services in 2018!

Wishing everyone a peaceful new year! 

Jiske Erlings, jerlings@leprastichting.nl
Infolep Information officer
 

 

 


 

Highlighted publications

 


 

World Leprosy Day 2018
Check out the new Infolep WLD2018 resources pages for an overview of recent research publications on childhood leprosy & prevention of disability in children.
https://www.leprosy-information.org/keytopic/preventing-leprosy-related-disabilities-girls-and-boys

Leprosy Review - 2017 nr 4
Read online here

Reaching a Billion. Ending Neglected Tropical Diseases. Fifth progress report on the London Declaration on NTDs. - 2017
Read online here

 


 

New publications

 


 

A novel vitamin D receptor polymorphism associated with leprosy.
Araújo TG, Oliveira GP, de Matos Oliveira F, et al. J. Dermatol. Sci. 2017.
Read abstract
 


Childhood leprosy in the postelimination era: A vision achieved or a concern growing at large.
Babu A, Bhat RM, Jayaraman J. Indian J Paediatr Dermatol. 2018;19(1):26-30.
Download PDF
 


Health-related quality of life amongst people affected by erythema nodosum leprosum in Bangladesh: a cross sectional study.
Bowers B, Butlin RC, Alam K, et al. Lepr Rev. 2017; 88(4):488–498.
Download PDF
 


The repetitive element RLEP is a highly specific target for the detection of Mycobacterium leprae.
Braet S, Vandelannoote K, Meehan CJ, et al. J. Clin. Microbiol. 2018.
Download PDF
 


Histological spectrum of pure neuritic leprosy with atypical clinical presentation at a tertiary care centre.
Chatterjee D, Kapatia G, Saikia UN, et al. Lepr Rev. 2017; 88(4):478–487.
Download PDF
 


Drug resistance pattern of Mycobacterium leprae from mouse footpad cultivation between 1997 to 2013 in Malaysia.
Dalawi I, Tang MM, Osman AS, et al. Lepr Rev. 2017; 88(4):463-477.
Download PDF
 


Use of fine needle aspirate from peripheral nerves of pure-neural leprosy for cytology and polymerase chain reaction to confirm the diagnosis: a follow-up study of 4 years.
De A, Hasanoor Reja AH, Aggarwal I, et al. Indian J Dermatol. 2017; 62(6):635-643.
Download PDF
 


Psychometric evaluation of the SARI stigma assessment scale and an understanding of stigma amongst people affected by leprosy in Iran.
Ebrahimi H, Bayat ZS, Ravesh NN, et al. Lepr Rev. 2017; 88(4):554–562.
Download PDF
 


Analysis of the epidemiological situation of leprosy in an endemic area in Brazil: spatial distribution in the periods 2001 - 2003 and 2010 - 2012.
de Freitas LRS, Duarte EC, Garcia LP. Rev Bras Epidemiol. 2017; 20(4):702-713.
Download PDF
 


Retrospective active case finding in Cambodia: an innovative approach to leprosy control in a low-endemic country.
Fürst T, Cavaliero A, Lay S, et al. Acta Trop. 2017.
Download PDF
 


Peripheral neuropathy is not the end but the beginning.
El Gency HI, Ghanema M, Hussein SA. Lepr Rev. 2017; 88(4): 574- 582.
Download PDF
 


Pure neuritic leprosy.
Forgione P, Barabino G, Cavalchini A, et a. G Ital Dermatol Venereol. 2018 Feb;153(1):124-126.
Read abstract
 


Hansen's disease: An unusual presentation.
George T, Venkataraman M, Mukhopadhyay S, et al. J Family Med Prim Care. 2017; 6(3):666-668.
Download PDF
 


Swan neck deformity mimicking claw hand caused by arthritis in leprosy.
Gunawan H, Haryati NS, Suwarsa O. Case Rep Dermatol. 2017 Nov 14;9(3):231-235.
Download PDF
 


High occurrence of disabilities caused by leprosy: census from a hyperendemic area in Brazil's savannah region.
Haefner K, Walther F, Chichava OA, et al. Lepr Rev. 2017; 88(4):520–532.
Download PDF
 


Incidence of mycobacterial disorders in Indian adult male service population followed for over two decades.
Hari Kumar KVS, Patnaik SK. J Infect Public Health. 2017.
Download PDF
 


Ten failings in global neglected tropical diseases control.
Hotez PJ. PLoS Negl Trop Dis. 2017 Dec 21;11(12):e0005896.
Download PDF
 


Disfiguring facial lesions and loss of sensation.
Hundemer M, Wan CR. JAAPA. 2018; 31(1):27-29.
Read abstract
 


Indicators related to physical disability and diagnosis of leprosy / Indicadores relacionados a incapacidade física e diagnóstico de hanseníase.
de Leano HAM, et al. Rev Rene. 2017 Nov-Dec; 18(6):832-9.
Download PDF
 


Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression.
Lima HR, Gasparoto TH, de Souza Malaspina TS, et al. Front Immunol. 2017 Dec 11;8:1724.
Download PDF
 


Arresting Leprosy: Therapeutic Outcomes Besides Cure.
López RN. Am J Public Health. 2018 Feb;108(2):196-202.
Read abstract
 


Enhanced active case-finding, identifying leprosy cases missed by recent detection campaigns in Munger District, Bihar, India.
Mangeard-Lourme J, Singh A, Singh RK, et al. Lepr Rev. 2017; 88(4):452–462.
Download PDF
 


Epidemiology of leprosy in Iran from 2005 to 2015.
Mansori K, Ayubi E, Nasehi M, et al. Tanaffos. 2017; 16(2):144-148.
Download PDF
 


Evaluation of 16S rRNA qPCR for detection of Mycobacterium leprae DNA in nasal secretion and skin biopsy samples from multibacillary and paucibacillary leprosy cases.
Marques LEC, Frota CC, da Quetz JS, et al. Pathog Glob Health. 2017:1-7.
Read abstract
 


Elevated pentraxin-3 concentrations in patients with leprosy: potential biomarker of erythema nodosum leprosum.
Mendes MA, de Carvalho DS, Amadeu TP, et al. J Infect Dis. 2017 Dec 19; 216(12):1635-1643.
Read abstract
 


A case report of erythroderma in a patient with borderline leprosy on reversal reaction: a result of the exacerbated reaction?
Miyashiro D, Vieira AP, Trindade MAB, et al. BMC Dermatol. 2017 Dec 20;17(1):16.
Download PDF
 


Multibacillary leprosy and the elderly: a field for further research.
Nobre ML, Amorim FM, De Souza MCF, et al. Lepr Rev. 2017; 88(4):510–519.
Download PDF
 


Historical perspectives on leprosy control in Nigeria: problems and prospects.
Okeke T, Nwankwo IU. International journal of health and social inquiry. 2017; 3(1):141-151.
Download PDF
 


Leprosy: An overview of epidemiology and risk factor in Indonesia.
Prakoeswa FRS, Sutrisna EM. J.Bio.Innov. 2017; 6(6):991-995.
Download PDF
 


The influence of cognitive behaviour therapy to decrease the level of depression for leprosy sufferer.
Rahmawati I, Yuniarti EV. IJNM. 2017; 1(1):69-73.
Download PDF
 


Study of radiological changes of bones in leprosy patients.
Reddy BK, Sreedevi L, Suryanarayana S. AIMDR. 2017; 4(1):5-8.
Download PDF
 


The impact of seasonal climate on new case detection rate of leprosy in Brazil (2008–2012).
Rocha ACAA, Junger WL, Da Cruz WJA, et al. Lepr Rev. 2017; 88(4):533-542.
Download PDF
 


Surveillance of intradomiciliary contacts of leprosy cases: perspective of the client in a hyperendemic municipality.
Romanholo HSB, Souza EA, Ramos Jr AN, et al. Rev Bras Enferm [Internet]. 2018;71(1):163-9.
Download PDF

 


The impact of Erythema nodosum leprosum on health related quality of life in Rio de Janeiro.
Sales AM, Illarramendi X, Walker SL, et al. Lepr Rev. 2017; 88(4):499–509.
Download PDF
 


Familial clustering of severe atypical variants of erythema nodosum leprosum in immunocompetent siblings.
Sanke S, Chander R, Kumar A. Lepr Rev. 2017; 88(4):568–573.
Download PDF
 


WHO leadership is essential for the elimination of NTDs.
Savioli L, Daumerie D. Lancet. 2018 Dec 23; 390(10114):2765.
Download PDF
 


Electrophysiological study of nerves in type-II reaction in leprosy.
Singh SK, Gupta SK, Mukhija RD, et al. Indian J Dermatol. 2017 Nov-Dec; 62(6):644-648.
Download PDF
 


The experiences of people affected by leprosy who participated in self-care groups in the community: A qualitative study.
Susanto T, Dewi EI, Rahmawati I. Lepr Rev. 2017; 8:1-11.
Download PDF
 


Humanitarian quarantine in practice: medicine, religion and leprosy in New Caledonia.
Sykes IJ. Anthropol Med. 2017; 24(3):301-318.
Read abstract
 


Household expenditure on leprosy outpatient services in the Indian health system: A comparative study.
Tiwari A, Suryawanshi P, Raikwar A, et al. PLoS Negl Trop Dis. 2018 Jan 4; 12(1):e0006181.
Download PDF
 


Active case detection of leprosy among indigenous people in Sarawak, East Malaysia.
Utap MS, Kiyu A. Lepr Rev. 2017; 88(4):563–567.
Download PDF
 


Leprosy: An Early Exemplar of the Transformation of 20th Century American Medicine.
Weisz G.Am J Public Health. 2018 Feb;108(2):160-161.
Read abstract
 


Evaluation of the economic burden of leprosy among migrant and resident patients in Guangdong Province, China.
Xiong M, Li M, Zheng D, et al. BMC Infect Dis. 2017 Dec 11;17(1):760.
Download PDF
 


Distribution of CD4+RORg-T Th17 And CD25+ FOXP3+ Treg in leprosy patient with reversal reaction.
Yuniati R, Riawan W, Widasmara D, et al. J.Biomed.Transl. Res. 2017; 3(2):30-33.
Download PDF
 


A pathway-based association analysis identified FMNL1-MAP3K14 as susceptibility genes for leprosy.
Zhang H, Wang Z, Fu X'an, et al. Exp. Dermatol. 2017.
Read abstract

 

 


 

Journals & Newsletters

 


 

Disability, CBR & Inclusive Development: http://dcidj.org/

Hansenologia Internationalis: http://www.ilsl.br/revista/atual.php

Indian Journal of Leprosy: http://www.ijl.org.in/index.html 

Leprosy Review: https://www.lepra.org.uk/Pages/FAQs/Category/volume-88
Leprosy Review Repository (1928-2001) : http://leprev.ilsl.br/arquivo.php

Plos Neglected Tropical Diseases: http://journals.plos.org/plosntds/
 
Revista de Leprología:
http://www.leprosy-information.org/resource/revista-de-leprologia
 
WHO Goodwill Ambassador's Newsletter for the elimination of leprosy:
http://www.smhf.or.jp/e/ambassador/index.html


 

 


 

Websites & Services

 


 

Global Leprosy Programme http://www.searo.who.int/entity/global_leprosy_programme/en/

LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in this theme to share ideas, information, experiences and questions.
http://leprosymailinglist.blogspot.nl/

InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs) https://www.infontd.org/



LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com